Journal CME 34.10: Neuronal Vulnerability in Parkinson's Disease and Putative Therapeutics: Should the focus be on axonal and synaptic terminals?

Be the first to review this product

Availability: In stock

$50.00

Quick Overview

Member price: $0.00


CME Credits: 1

Journal CME 34.10:  Neuronal Vulnerability in Parkinson's Disease and Putative Therapeutics: Should the focus be on axonal and synaptic terminals?

Double click on above image to view full picture

Zoom Out
Zoom In

More Views

Details

While current effective therapies areavailable for the symptomatic control of PD, treatments to halt the progressive neurodegeneration still do not exist. Loss of dopamine neurons in the SNc and dopamine terminals in the striatum drive the motor features of PD. This module will take you approximately 1 hour to complete. Faculty: Yvette C. Wong, PhD, Kelvin Luk, PhD Kerry Purtell, PhD Samuel Burke Nanni, MSc A. Jon Stoessl, MD, Louis-Eric Trudeau, PhD Zhenyu Yue, PhD Dimitri Krainc, MD, PhD Wolfgang Oertel, MD, Jose A. Obeso, MD, PhD Laura A. Volpicelli-Daley, PhD

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.